Specific inhibition of the humoral component of the immune response by passively administered antibody has been demonstrated in a variety of experimental systems indicating the important role of antibody as a feedback factor during immune response (1-8, and earlier references quoted in reference 1). Both 19S and 7S antibodies have been found to function as inhibitors, 7S as a rule being more efficient than 19S antibodies (6-8). Passively transferred antibody has been found particularly efficient as an inhibitor if administered prior to or during the induction of both 19S and 7S antibody synthesis, whereas an already producing 7S system has been considered more resistant to inhibition than a comparable 19S system (6-8). This difference between the two antibody systems is in agreement with findings t h a t 7S synthesis in most systems is very long-lived compared to 19S production indicating either that the 7S-producing system is not as easily depleted of antigen as is the 19S system or the 7S synthesizing cells are very long-lived even in complete absence of antigen 9-12).
The antisera used to develop 7S plaques in the indirect hemolytic plaque test (14, 15) were produced in rabbits immunized with mouse 7S antibodies by the following technique. Mouse anti-human serum albumin (HSA) antibodies of 7S type were obtained after gel filtration on Sephadex G-200. The antibodies were absorbed onto HSA-coated acryl plast particles (BoforsNobelkrut, Bofors, Sweden) at room temperature for i to 2 hr (17) . The particles, now coated with HSA-anfi-HSA complexes were washed twice and inoculated into rabbits as 1 ml of a 3% suspension. The rabbits were bled 8 to 10 days after the last of four weekly injections. This procedure regularly yielded antisera with optimal developing activity for 7S plaques (13, 14) at dilution 1 : 100.
Serological Procedures.--Hemagglutination was carried out in the presence of PVP according to Stimpfling (18) . Hemolysis was carried out as previously described (19) but using Cr ~-labeled target cells measuring the isotope release in a well-type scintillation counter. This increased precision and allowed the use of 10% specific hemolysis to be used as end point in titrations. Indirect hemolysis was carried out by incubating the cells with antiserum as in ordinary hemolysis for i hr at 37°C, washing once and adding the rabbit-anti-mouse 7S antiserum diluted 1:100 together with complement. Fractionation of antisera into 19S and 7S fractions was carried out on Sephadex-200 (19) . 2-mercaptoethanol (2ME-) inactivation was carried out according to Uhr and Finkelstein (9) .
Hemolytic Plaque Tests.--The direct hemolytic plaque test detecting predominantly 19S-producing cells (13, 19 ) was carried out as described by Jerne et al. (13) . The indirect hemolytic plaque test detecting 7S-producing cells (14) (15) (16) was carried out according to Dresser and Wortis (15) . A high degree of inhibition of 19S plaques was found when using our unabsorbed rabbit-anti-mouse 7S antiserum confirming the findings of others (15) . Using our unabsorbed antiserum in two experimental systems where only 19S antibody synthesis could be recorded the average inhibition of 19S plaques in 22 different tests was found to be 80.4% (st. = 4.1%) (20) . Thus, in the present tests when unabsorbed rabbit-anti-mouse 7S antiserum was used 20% of the number of plaque-forming cells (PFC) found in the direct hemolytic test was subtracted from the values obtained in the indirect test in order to obtain the nearest approximation to the true 7S PFC number. Although the exact mechanism of inhibition of 19S PFC by our rabbit-anti-mouse 7S antiserum is unknown, absorption of the antiserum with purified mouse 19S antibodies reduces the 19S-inhibiting capacity of the antiserum to approximately 5% leaving the capacity intact to develop 7S PFC (21) .
Inhibition Experiments.--Each mouse was immunized intravenously with a standard dose of 4 X 108 SRBC and in several experiments received simultaneously 4 X 10 s ChRBC by the same route. At different time intervals thereafter half of the animals received one or several injections of anti-SRBC or anti-ChRBC antisera. The other half of the group received the same dose of normal mouse serum. At different periods after antiserum administration, the animals were bled, killed, and their number of 19S and 7S PFC against SRBC and ChRBC in the spleens were determined.
RESULTS

I~ir~t Hemolysis at the Cellular and Serum LeveL--The inoculation of 4 X
l0 s sheep red blood cells intravenously cause direct and indirect hemolytic plaque-forming cells (PFC) to appear as shown in Fig. 1 . A similar figure was obtained when chicken red blood cells were inoculated. The number of direct hemolytic plaque-forming cells in the spleen reached the peak around day 4 to 5 after antigen administration followed by a rapid decrease. The 19S serum titers were found to run parallel to the number of direct plaque-forming cells in accordance with previous findings (19) . The peak of indirect PFC was found around day 5 to 8 and the number was subsequently decreasing at a much slower rate than the corresponding direct PFC. Substantial numbers of indirect PFC could be found several months after a single antigen dose of this magnitude. The peak serum titer of 7S antibodies whether measured in hemagglutination or indirect or direct hemolysis was appearing around day 10 to 16 after ~mmUlfization. The decay of 7S serum titers after peak titer were found to go parallel to the decrease in the number of indirect PFC in the spleen. The discrepancy between peak time of indirect PFC and 7S serum titer is partly explained by the tendency of 7S antibodies to accumulate (half-life of passively administered hemolytic anti-SRBC 19S antibody = 8 to 12 hr; half-life of 7S antibody = 3 to 4 days). If 19S and 7S antibodies from a mouse-anti-SRBC antiserum are separated by gel filtration and subsequently tested in direct and indirect hemolysis the indirect hemolysis shows enhancement of the direct 7S hemolytic titer by a factor of 300 as shown in Fig. 2 . Instead inhibition of 19S hemolysis of at least one dilution step was a common finding. This specific potentiating effect of the 7S hemolysis in indirect hemolysis using a rabbit-anti-mouse 7S antiserum is in accordance with previous findings (14, 15) .
For simplicity, the direct hemolytic plaque-forming cell will hereafter be referred to as 19S PFC and the indirect plaque-forming cell as 7S PFC (for calculation of 7S PFC in the presence of 19S PFC see Material and Methods).
Inhibition of 7S PFC by Passively Administered Antibody.--Alt mice received
the standard dose of SRBC intravenously. In most experiments the animals received a simultaneous injection of ChRBC. At different time intervals thereafter, half of the group received passively transferred anti-SRBC or, in two experiments, anti-ChRBC antibodies, whereas the other half received the same amount of normal mouse serum. The passively administered antibodies, ranging in fiters of 2-ME-resistant agglutinins from 38 to 3 TM, were transferred in volumes from 0.001 to 0.5 ml in order to administer the desired number of antibody units. In certain experiments the animals received repeated inoculations of antibodies in order to prolong the action of transferred antibody. The effect of passively administered anti-SRBC antibodies on the number of 19S and 7S PFC against SRBC in the spleen using two different mouse strains is shown in Figs. 3 and 4. The results clearly indicate that both types of PFC are inhibited by the transferred antibodies even when the antiserum is administered as late as 23 days after immunization, long after the peak of both 19S and 7S synthesis has passed (see Fig. 1 ). Table I summarizes the results obtained under varying experimental conditions. They show that inhibition of 7S PFC can be obtained even when passive administration of antibodies is not started until 40 days after immunization. This inhibition is specific as shown by two sets of controls. All inhibiting anti-SRBC antisera were tested at least once for their possible unspecific inhibitory effect against an unrelated antigen, ChRBC. As seen in Table I (Experiments 1, 2, and 4 to 12) no indication of depressive effect of administered anti-SRBC antibody on the number of PFC against ChRBC was seen. Furthermore, Experiments 3 and 6 in Table I where anti-ChRBC anfisera were administered exclude that the anti-SRBC system might be particularly sensitive to the administration of any kind of "immune" serum. In these experiments no reduction
. o e- bility were carried out using antiserum-treated and normal spleen cell suspensions, (Table I, ceils from Experiments 1, 4, and 9). Equal parts of the inhibited and normal cell suspension were tested separately or mixed together for the presence of 7S PFC and the outcome of these experiments (Table II) show that no nonspecific inhibition in vitro of 7S PFC was found.
There was a general tendency of 7S PFC to become more resistant to inhibi- 
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.~ tion with time despite keeping the same or higher relative increase in 2-MEresistant agglutinins through passively administered antibody (see Table I , Experiments 2, 4, and 5). Finally, this resistance turned out to be almost complete as in the group where antibody was not administered until day 90 after immunization, only a weak and not significant inhibition was found despite a twentyfold increase of 2-ME-resistant agglutinins through repeatedly transferred antibodies for 13 days (Table I , Experiment 12). Table I . The first figure denotes the day after immunization at which antibody was administered, the second figure refers to number of days after antibody transfer before testing.
§ Each experiments consist of one control and one antiserum-treated animal. 1:10 of a spleen was plated separately on two plates, and on two plates a mixture of 1:20 from each spleen was plated. The mean values observed and expected are shown. All PFC values have been multiplied by a factor of 10.
A few experiments were carried out in order to study in detail the time needed for passively administered antibody to start inhibiting 7S PFC. As shown in Fig. 5 no inhibition is apparent until at least 48 to 72 hr after transfer of antibodies. The number of 7S PFC in antiserum-treated and normal animals were identical at 24 hr after antibody administration, close to identical at 48 hr, but significantly different at 72 hr. Similar results were obtained in Experiments 1 and 9 in Table I , whereas longer time was needed in Experiment 11, when transfer of antibody was delayed until 40 days after immunization. In no experiment was inhibition observed before 48 hr after antibody administration irrespective of the magnitude of passive increase of 2-ME-resistant agglutinins in the sera of the recipient animals.
Inhibition of 7S Antibody Synthesis of Intact Mouse by Transferred Anti-
bodies.--In order to exclude that the antibody-induced inhibition of 7S antibody synthesis was a unique characteristic of the spleen cell population the serum titers of 2-ME-resistant agglutinins were followed in mice receiving antigen and passively administered antibody in the way previously described. Sufficient time was allowed for the transferred antibody to decay before serum titers were determined. Fig. 6 and Table III summarize the results obtained indicating that the passively administered antibody does inhibit 7S antibody synthesis of the intact animals as it does with 7S antibody production of the spleen. A similar increase in resistance with time to antibody-induced inhibition was also found in the 7S whole-body synthesis. Fig. 7 shows the results obtained (Table III, 2-ME-resistant agglutinins constant. 35 days after last antiserum transfer all animals were bled and tested for 2-ME-resistant agglutinins. Using a twentyfold passive increase in 2-ME--resistant agglutinins the 7S antibody system started to become resistant to suppression by the antiserum used if this was administered later than 20 days after immunization. Thus, 7S antibody production of the intact animal seemed to react in the same ways as 7S synthesis of the spleen with regard to sensitivity to antibody-induced inhibition. became evident that the transferred antibodies are probably not inhibiting already commltted cells, as there was a lag of 40 to 50 hr before any detectable decrease in the number of 19S PFC (8) . The present data confirm this finding and extend it to the 7S system where no suppression of synthesis became apparent until at least 48 to 72 hr after antibody transfer.
It is not known in the present system whether recruitment of 7S-producing cells or division or mere survival of already synthesizing cells are playing the major roles in maintaining 7S antibody production in the postpeak period. Although the data do not allow any discrimination between these alternatives they show that at least during the 1st month(s) after induction 7S antibody synthesis is still dependent upon something which in a specific way is removed from the system by passively transferred antibody. The exact mechanism through which antibodies suppress the ~immune response is unknown but there is no evidence to exclude that they act by combining with antigenic determinants. It has been reported that flagellar antigens of bacteria are not detectable in the specific antibody-producing cells (22) . If erythrocyte antigens are not present in the synthesizing cells it would follow that antigen localized in some other cell type(s) would be responsible for stimulating 7S antibody synthesis according to the above mentioned alternatives. The fact that inhibition of 7S antibody production did not become evident until 48 to 72 hr after antibody transfer would indicate a corresponding lifetime of these specific stimulating factors.
It has previously been found that 19S antibody synthesis is inhibited more easily by 7S antibodies than by 19S antibodies (6, 8) . In the present system different batches of 7S antibodies with approximately the same titers of 2-MEresistant agglutinins have been found to differ markedly with regard to capacity to inhibit 7S antibody synthesis, being increasingly efficient with increasing number of immunizations (references 8 and 21, andpresent article). Similar findings have been reported by Finkelstein and Uhr (6) when testing 7S antisera with the same phage-neutralizing activity in vitro for their capacity to inhibit the immune response in vivo. These results indicate a change with time within or between type of 7S antibodies being produced after immunization. This is consistent with the known existence of a number of 7S immunoglobulin classes (23) and the changes of characteristics within an immunoglobulin class tAklng place with time after immunization (24) . One might speculate that a gradual change into production of more efficient inhibiting antibodies not necessarily correlated to changes in the titer of 2-ME-resistant agglutlnlns could explain the increasing resistance with time to antibody-induced suppression in the present 7S system. Thus, antibody transfer causing a passive increase in 2-MEresistant agglutinins might not be correlated to a corresponding increase in "efficient inhibiting" antibodies thus failing to inhibit 7S antibody synthesis. However, an alternative explanation of the increasing resistance of the 7S antibody system to antibody-induced inhibition would be the accumulation of long-lived 7S-producing cells like certain plasma cells in the rat (25) , which may survive for prolonged periods in the absence of antigen. Studies using radioautography are in progress trying to solve this question.
Taken together the present data suggest that antigen is of major importance in maintaining and stabilizing 7S antibody synthesis during a prolonged period after induction of 7S antibody production against erythrocyte antigens. They also emphasize the role of antibody functioning as a feedback factor during immune response both with regard to 19S and 7S antibody synthesis. The specific suppressing activity of passively administered antibody on 7S antibody synthesis against sheep and chicken red blood cells has been investi-gated at the cellular level using the indirect hemolytic agar-plaque technique. 7S antibody production was found to be sensitive to antibody-induced suppression. No inhibitory effect of transferred antibody was seen until 48 to 72 hr after administration. This indicates that the action of antibody is not by direct suppression of synthesis of already committed cells but rather by removal from the system of the stimulus for maintenance of 7S synthesis. The sensitivity of the 7S system to inhibition decreases with time after immunization but significant specific suppression could still be obtained if transfer of antibody was delayed until 40 days after immunization. The present findings emphasize the role of antibody as a feedback factor during a substantial postpeak period of 7S antibody synthesis and suggest an important role of antigen in stabilizing the 7S antibody production.
